Insight Molecular Diagnostics (IMDX) FCF Margin Growth (1y) (2021 - 2026)
Insight Molecular Diagnostics (IMDX) FCF Margin Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,529.42 Bn | 30,528.96 Bn | 1.11 Bn | -3,866.00 |
| 2 | Thermo Fisher Scientific | 183.75 Bn | 180.50 Bn | 7.74 Bn | 393.00 |
| 3 | Danaher | 133.13 Bn | 127.43 Bn | 3.59 Bn | -13.00 |
| 4 | Idexx Laboratories | 46.14 Bn | 45.94 Bn | 722.74 Mn | 179.00 |
| 5 | Agilent Technologies | 38.20 Bn | 36.39 Bn | 990.00 Mn | 454.00 |
| 6 | Natera | 31.50 Bn | 30.40 Bn | 696.04 Mn | -192.00 |
| 7 | Iqvia Holdings | 31.34 Bn | 29.36 Bn | 1.36 Bn | 70.00 |
| 8 | Illumina | 24.51 Bn | 23.36 Bn | 721.00 Mn | 303.00 |
| 9 | Mettler Toledo International | 23.53 Bn | 23.47 Bn | 555.82 Mn | -713.00 |
| 10 | Insight Molecular Diagnostics | 4.52 Mn | -24.41 Mn | 15,000.00 | -2.55 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.55 Mn |
| Dec 31, 2025 | -24,219.00 |
| Sep 30, 2025 | 274,896.00 |
| Jun 30, 2025 | 464,853.00 |
| Mar 31, 2025 | 190,231.00 |
| Dec 31, 2024 | 111,850.00 |
| Sep 30, 2024 | -413,726.00 |
| Jun 30, 2024 | -445,614.00 |
| Mar 31, 2024 | 60,484.00 |
| Dec 31, 2023 | 232,087.00 |
| Sep 30, 2023 | 1.75 Mn |
| Jun 30, 2023 | 374,171.00 |
| Mar 31, 2023 | 111,012.00 |
| Dec 31, 2022 | -360,584.00 |
| Sep 30, 2022 | -1.71 Mn |
| Jun 30, 2022 | -479,030.00 |
| Mar 31, 2022 | -295,483.00 |
| Dec 31, 2021 | 104,645.00 |
| Sep 30, 2021 | 2,056.00 |
| Jun 30, 2021 | 478,419.00 |